FDA Inspection 1256389 — GMP Laboratories Of America Inc

GMP Laboratories Of America Inc — FEI 3002710875

The FDA completed an inspection of GMP Laboratories Of America Inc on Dec 16, 2024 in Anaheim, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 16, 2024
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Anaheim, CA (United States)

Citations

IDCFRDescription
122021 CFR 211.67(b)(3)Cleaning SOPs/instructions
135821 CFR 211.100(b)SOPs not followed / documented
136121 CFR 211.100(a)Absence of Written Procedures
203121 CFR 211.194(a)Complete test data included in records

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.